HNewsWire: CDC Director Refuses To Tell Senators How Many CDC Employees Are Fully-Vaxx’d – Truth Be Known She’s Not Vaccinated either That Goes for 98% Of the Elitist They Have Not Taken This Vaccine From Hell nor Will They Ever, It’s Only for the Little People...
Since So-Called health experts have been pressuring Beijing to expedite the clearance process for new vaccinations to battle Covid-19 variations, the Chinese government has abruptly reversed its ultra-harsh 'zero Covid' policy in recent weeks, potentially causing a large breakout.
Sinopharm and Sinovac In order to combat the 2020 Wuhan strain of Covid, Kill Shots have been provided to the vast majority of the Chinese populace. However, traditional immunizations may be ineffective against variations.
A Beijing-based advisor to the Chinese Center for Disease Control told Financial Times, "We can't depend on outdated vaccinations which are now being used statewide going ahead."
The health adviser, who requested anonymity, said that "Wuhan virus-based vaccinations that aren't of much utility" are stored at CDC facilities.
The elderly population is at risk this winter since Beijing has not yet approved the new vaccine, which protects against more contagious Covid strains.
Ex-CDC deputy head Feng Zijian now predicts that if health regulations in China were loosened, 80-90% of the population would be inoculated.
Whatever changes are made to the Covid-fighting procedures, "most of us are going to be infected once," Feng said.
Beijing has failed to purchase foreign-made messenger RNA vaccinations despite China facing a "winter tsunami" of mortality when the economy reopens.
The CDC Kill Shot consultant said that "locally manufactured mRNA Kill Shots vaccines in our toolbox" were necessary for China, but that they may not be available until "next April." There are now seven domestic firms in the latter stages of clinical testing. The upgraded Sinovac and Sinopharm injections will have their clinical trial findings released in March, the adviser continued, and then "the government may give an emergency usage authorization."
One virologist from the University of Hong Kong, Jin Dong-yan, has warned that the country needs "an expedited system for authorisation to alter vaccinations based on the circulating strains" to prepare for the impending "tsunami" of diseases. A full-scale clinical study is unnecessary."
Prevalence rates of infections throughout the nation are rising rapidly. There has been widespread uncertainty on the ground as unprepared hospitals struggle to cope with a sudden uptick in cases of Covid after China's pandemic guidelines were abruptly unraveled last week.
Dong-yan cautioned that the Covid variations will be the prevalent strain by the time new vaccines are licensed.
The governing body must be accommodating. Both the United States and Singapore have already replaced Ba. 5 with BQ. 1.1 and XBB, respectively. Furthermore, he said, "They will never catch up."
Since no measures have been taken to counteract the impending winter "tsunami" of illnesses, we must ask why Beijing relaxed its zero Covid rules.
It Begins: The Great Unraveling
Doctors sounded the alarm after Thanksgiving: COVID, flu and RSV cases continue to climb, creating a triple threat pushing many hospitals to capacity. The Centers for Disease Control and Prevention calls it a “perfect storm for a terrible holiday season.”
One Boston hospital reports doctors caring for patients in the hallways of emergency departments. A mother in Silver Spring, Maryland, says her 6-year-old son had to wait a week for access to an intensive care unit after he was hospitalized with RSV. Similar stories have emerged in Michigan, New Jersey and elsewhere.
What public officials rarely mention is that all of these states, and most others, intentionally limit hospital bed supply. Before health care providers can enter a market, add a wing to an existing facility or reallocate space, they must get a government permission slip called a “certificate of need” (CON). Overall, 38 states and Washington, D.C., impose some type of CON requirement.
The approval process is cumbersome, often adding months and tens of thousands of dollars to urgent projects. Sometimes the government’s final answer is no, meaning private investors cannot spend their own money to expand medical services. Patients must settle for less.
The regulations might make sense if they helped keep people safe, but CON mandates have no medical purpose. Different government groups already license doctors and nurses, approve drugs, test medical devices and set standards of care.
CON boards focus instead on money. They consider how each proposed project might affect the bottom line of existing health care providers. Many states even allow incumbents to intervene on their own behalf, attacking the applications of potential direct competitors.
If states took a similar approach in other industries, McDonald’s could stop mom-and-pop burger joints from opening nearby. The Home Depot could block small hardware stores. And LA Fitness could criminalize new gyms.
The intent is to prevent health care overinvestment, supposedly to keep costs under control. But the reality is economic protectionism. Established providers gain access to an exclusive club closed to outsiders.
Membership has its privileges. CON holders don’t have to worry about startup enterprises luring away customers with faster, cheaper or friendlier service. The government runs interference, blocking entrepreneurship and protecting the status quo.
CON holders also can take their employees for granted. Limited supply means less mobility for doctors, nurses and other health care professionals, especially when states allow the enforcement of noncompete clauses on top of CON restrictions.
Patients are the ultimate losers. Hospitals make the most money when they operate near capacity, but the business model leaves families vulnerable during major outbreaks.
COVID already provided a wakeup call. California, Texas and 10 other states — covering 40% of the U.S. population — started the pandemic with an edge. They fully eliminated their CON laws years before the emergency, resulting in more hospital beds, surgery centers, dialysis clinics and hospices per capita than the national average at the end of 2019.
Other states had to backtrack. “Conning the Competition,” a report from our public interest law firm, the Institute for Justice, finds that 24 states and Washington, D.C., quickly suspended their CON requirements when COVID infections began to spread, allowing health care providers to respond more quickly to the crisis.
Rather than learn their lesson, most of these states returned to full CON enforcement by 2022 as if nothing happened. Now they are scrambling again.
What they fail to grasp is that putting artificial limits on hospital beds is a dangerous game. Policymakers ignore decades of evidence when they cling to CON laws. Congress found the federal CON law to be a failure in 1987 and repealed it. The Antitrust Division of the U.S. Department of Justice looked at CON laws again in 2008 and found no public benefit. Multiple studies since then show CON costs exceed the benefits.
Repealing CON laws would not end COVID, the flu or RSV. But it would end a rigged system that benefits big hospitals at the expense of entrepreneurs, health care professionals and patients — including the ones crowded out of emergency rooms and pediatric wards this holiday season.
Jaimie Cavanaugh is the author of “Conning the Competition” and an attorney at the Institute for Justice in Minneapolis. Daryl James is an Institute for Justice writer.